Compile Data Set for Download or QSAR
Report error Found 49 Enz. Inhib. hit(s) with Target = 'Nuclear receptor coactivator 2 [740-753]'
TargetNuclear receptor coactivator 2 [740-753]()
Centaurus Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 205040BDBM205040(n-(3-(2-(9h-purin-6-yl)phenylamino)-4-methylphenyl...)
Affinity DataIC50: 100nMAssay Description:In vitro B-RAF Kinase Assay. To determine iIn vitro activities of recombinant B-RAF enzyme, a Homogeneous Time-Resolved Fluorescence (HTRF) assay was...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Centaurus Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 205011BDBM205011(n-(3-(3-(9h-purin-6-yl)pyridin-2-ylamino)-2-chloro...)
Affinity DataIC50: 100nMAssay Description:In vitro B-RAF Kinase Assay. To determine iIn vitro activities of recombinant B-RAF enzyme, a Homogeneous Time-Resolved Fluorescence (HTRF) assay was...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Centaurus Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 205010BDBM205010(n-(3-(3-(9h-purin-6-yl)pyridin-2-ylamino)-4-chloro...)
Affinity DataIC50: 100nMAssay Description:In vitro B-RAF Kinase Assay. To determine iIn vitro activities of recombinant B-RAF enzyme, a Homogeneous Time-Resolved Fluorescence (HTRF) assay was...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Centaurus Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 205009BDBM205009(n-(3-(3-(9h-purin-6-yl)pyridin-2-ylamino)-4-methyl...)
Affinity DataIC50: 100nMAssay Description:In vitro B-RAF Kinase Assay. To determine iIn vitro activities of recombinant B-RAF enzyme, a Homogeneous Time-Resolved Fluorescence (HTRF) assay was...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Centaurus Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 205008BDBM205008(n-(3-(3-(9h-purin-6-yl)pyridin-2-ylamino)-4-chloro...)
Affinity DataIC50: 100nMAssay Description:In vitro B-RAF Kinase Assay. To determine iIn vitro activities of recombinant B-RAF enzyme, a Homogeneous Time-Resolved Fluorescence (HTRF) assay was...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Centaurus Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 205007BDBM205007(n-(3-(3-(9h-purin-6-yl)pyridin-2-ylamino)-4-fluoro...)
Affinity DataIC50: 100nMAssay Description:In vitro B-RAF Kinase Assay. To determine iIn vitro activities of recombinant B-RAF enzyme, a Homogeneous Time-Resolved Fluorescence (HTRF) assay was...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Centaurus Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 197677BDBM197677(US9216981, 5 | US9550781, 1)
Affinity DataIC50: 100nMAssay Description:In vitro B-RAF Kinase Assay. To determine iIn vitro activities of recombinant B-RAF enzyme, a Homogeneous Time-Resolved Fluorescence (HTRF) assay was...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Centaurus Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 197706BDBM197706(US9216981, 35 | US9550781, 15)
Affinity DataIC50: 100nMAssay Description:In vitro B-RAF Kinase Assay. To determine iIn vitro activities of recombinant B-RAF enzyme, a Homogeneous Time-Resolved Fluorescence (HTRF) assay was...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Centaurus Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 205013BDBM205013(n-(3-(3-(9h-purin-6-yl)pyridin-2-ylamino)-2,4-difl...)
Affinity DataIC50: 100nMAssay Description:In vitro B-RAF Kinase Assay. To determine iIn vitro activities of recombinant B-RAF enzyme, a Homogeneous Time-Resolved Fluorescence (HTRF) assay was...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Centaurus Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 205012BDBM205012(n-(3-(3-(9h-purin-6-yl)pyridin-2-ylamino)-4-chloro...)
Affinity DataIC50: 100nMAssay Description:In vitro B-RAF Kinase Assay. To determine iIn vitro activities of recombinant B-RAF enzyme, a Homogeneous Time-Resolved Fluorescence (HTRF) assay was...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Centaurus Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 197689BDBM197689(US9216981, 17 | US9550781, 24)
Affinity DataIC50: 100nMAssay Description:In vitro B-RAF Kinase Assay. To determine iIn vitro activities of recombinant B-RAF enzyme, a Homogeneous Time-Resolved Fluorescence (HTRF) assay was...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Centaurus Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 50165873BDBM50165873(US9550781, 19 | CHEMBL3800014)
Affinity DataIC50: 100nMAssay Description:In vitro B-RAF Kinase Assay. To determine iIn vitro activities of recombinant B-RAF enzyme, a Homogeneous Time-Resolved Fluorescence (HTRF) assay was...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Centaurus Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 205021BDBM205021(n-(3-(3-(9h-purin-6-yl)pyridin-2-ylamino)-2,4-difl...)
Affinity DataIC50: 100nMAssay Description:In vitro B-RAF Kinase Assay. To determine iIn vitro activities of recombinant B-RAF enzyme, a Homogeneous Time-Resolved Fluorescence (HTRF) assay was...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Centaurus Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 50030474BDBM50030474(US9562012, rosiglitazone | CHEBI:50122 | Avandamet...)
Affinity DataIC50: 125nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/3/2018
Entry Details
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Centaurus Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 205020BDBM205020(n-(3-(3-(9h-purin-6-yl)pyridin-2-ylamino)-2,4-difl...)
Affinity DataIC50: 500nMAssay Description:In vitro B-RAF Kinase Assay. To determine iIn vitro activities of recombinant B-RAF enzyme, a Homogeneous Time-Resolved Fluorescence (HTRF) assay was...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Centaurus Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 205017BDBM205017(n-(3-(3-(9h-purin-6-yl)pyridin-2-ylamino)-2,4-difl...)
Affinity DataIC50: 500nMAssay Description:In vitro B-RAF Kinase Assay. To determine iIn vitro activities of recombinant B-RAF enzyme, a Homogeneous Time-Resolved Fluorescence (HTRF) assay was...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Centaurus Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 50165871BDBM50165871(US9550781, 13 | CHEMBL3798635)
Affinity DataIC50: 500nMAssay Description:In vitro B-RAF Kinase Assay. To determine iIn vitro activities of recombinant B-RAF enzyme, a Homogeneous Time-Resolved Fluorescence (HTRF) assay was...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Centaurus Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 205014BDBM205014(n-(3-(3-(9h-purin-6-yl)pyridin-2-ylamino)-2,4-difl...)
Affinity DataIC50: 500nMAssay Description:In vitro B-RAF Kinase Assay. To determine iIn vitro activities of recombinant B-RAF enzyme, a Homogeneous Time-Resolved Fluorescence (HTRF) assay was...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Centaurus Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 205038BDBM205038(n-(3-(3-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)pyridin-2...)
Affinity DataIC50: 500nMAssay Description:In vitro B-RAF Kinase Assay. To determine iIn vitro activities of recombinant B-RAF enzyme, a Homogeneous Time-Resolved Fluorescence (HTRF) assay was...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Centaurus Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 205035BDBM205035(n-(3-(3-(1h-pyrazolo[3,4-d]pyrimidin-4-yl)pyridin-...)
Affinity DataIC50: 500nMAssay Description:In vitro B-RAF Kinase Assay. To determine iIn vitro activities of recombinant B-RAF enzyme, a Homogeneous Time-Resolved Fluorescence (HTRF) assay was...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Centaurus Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 205024BDBM205024(n-(3-(3-(9h-purin-6-yl)pyridin-2-ylamino)-2,4-difl...)
Affinity DataIC50: 500nMAssay Description:In vitro B-RAF Kinase Assay. To determine iIn vitro activities of recombinant B-RAF enzyme, a Homogeneous Time-Resolved Fluorescence (HTRF) assay was...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Centaurus Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 205005BDBM205005(n-(2,4-difluoro-3-(3-(8-methyl-9h-purin-6-yl)pyrid...)
Affinity DataIC50: 500nMAssay Description:In vitro B-RAF Kinase Assay. To determine iIn vitro activities of recombinant B-RAF enzyme, a Homogeneous Time-Resolved Fluorescence (HTRF) assay was...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Centaurus Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 205023BDBM205023(n-(3-(3-(9h-purin-6-yl)pyridin-2-ylamino)-2,4-difl...)
Affinity DataIC50: 500nMAssay Description:In vitro B-RAF Kinase Assay. To determine iIn vitro activities of recombinant B-RAF enzyme, a Homogeneous Time-Resolved Fluorescence (HTRF) assay was...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Centaurus Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 205015BDBM205015(n-(3-(3-(9h-purin-6-yl)pyridin-2-ylamino)-2,4-difl...)
Affinity DataIC50: 1.00E+3nMAssay Description:In vitro B-RAF Kinase Assay. To determine iIn vitro activities of recombinant B-RAF enzyme, a Homogeneous Time-Resolved Fluorescence (HTRF) assay was...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Centaurus Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 205042BDBM205042(n-(3-(2-(9h-purin-6-yl)phenylamino)-2,4-difluoroph...)
Affinity DataIC50: 1.00E+3nMAssay Description:In vitro B-RAF Kinase Assay. To determine iIn vitro activities of recombinant B-RAF enzyme, a Homogeneous Time-Resolved Fluorescence (HTRF) assay was...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Centaurus Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 50165865BDBM50165865(US9550781, 23 | CHEMBL3798423)
Affinity DataIC50: 1.00E+3nMAssay Description:In vitro B-RAF Kinase Assay. To determine iIn vitro activities of recombinant B-RAF enzyme, a Homogeneous Time-Resolved Fluorescence (HTRF) assay was...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Centaurus Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 205025BDBM205025(n-(3-(3-(9h-purin-6-yl)pyridin-2-ylamino)-2,4-difl...)
Affinity DataIC50: 1.00E+3nMAssay Description:In vitro B-RAF Kinase Assay. To determine iIn vitro activities of recombinant B-RAF enzyme, a Homogeneous Time-Resolved Fluorescence (HTRF) assay was...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Centaurus Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 228151BDBM228151(US9562012, 21 | (2s)-2-ethoxy-3-{4-[2-(3-methoxyph...)
Affinity DataIC50: 3.70E+3nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/3/2018
Entry Details
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Centaurus Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 228140BDBM228140(US9562012, 10 | (2s)-2-ethoxy-n-methoxy-3-{4-[(4-m...)
Affinity DataIC50: 7.90E+3nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/3/2018
Entry Details
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Centaurus Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 228150BDBM228150(US9562012, 20 | ethyl (2s)-2-ethoxy-3-{4-[2-(3-met...)
Affinity DataIC50: 1.09E+4nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/3/2018
Entry Details
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Centaurus Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 228137BDBM228137(US9562012, 7 | (2s)-2-ethoxy-3-{4-[(4-methoxypyrid...)
Affinity DataIC50: 1.18E+4nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/3/2018
Entry Details
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Centaurus Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 228129BDBM228129(US9562012, mitoglitazone)
Affinity DataIC50: 2.66E+4nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/3/2018
Entry Details
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Centaurus Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 228134BDBM228134(US9562012, 4 | ethyl (2s)-2-ethoxy-3-[4-(pyridin-2...)
Affinity DataIC50: 2.77E+4nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/3/2018
Entry Details
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Centaurus Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 228147BDBM228147(US9562012, 17 | ethyl (2r)-2-ethoxy-3-{4-[(2s)-2-h...)
Affinity DataIC50: 2.77E+4nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/3/2018
Entry Details
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Centaurus Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 228141BDBM228141(US9562012, 11 | (2s)-2-ethoxy-n-hydroxy-3-{4-[(4-m...)
Affinity DataIC50: 3.05E+4nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/3/2018
Entry Details
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Centaurus Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 228131BDBM228131(US9562012, 1 | ethyl (2s)-2-ethoxy-3-(4-hydroxyphe...)
Affinity DataIC50: 5.89E+4nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/3/2018
Entry Details
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Centaurus Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 228143BDBM228143(US9562012, 13 | (2r)-2-ethoxy-3-{4-[2-(3-methoxyph...)
Affinity DataIC50: 6.14E+4nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/3/2018
Entry Details
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Centaurus Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 228138BDBM228138(US9562012, 8 | (2s)-2-ethoxy-n-hydroxy-3-{4-[(4-me...)
Affinity DataIC50: 9.85E+4nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/3/2018
Entry Details
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Centaurus Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 228132BDBM228132(US9562012, 2 | ethyl (2r)-2-ethoxy-3-(4-hydroxyphe...)
Affinity DataIC50: 1.00E+5nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/3/2018
Entry Details
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Centaurus Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 228142BDBM228142(US9562012, 12 | ethyl (2r)-2-ethoxy-3-{4-[2-(3-met...)
Affinity DataIC50: 1.64E+5nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/3/2018
Entry Details
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Centaurus Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 228146BDBM228146(US9562012, 16 | (2r)-2-ethoxy-3-{4-[(2s)-2-hydroxy...)
Affinity DataIC50: 1.91E+5nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/3/2018
Entry Details
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Centaurus Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 228136BDBM228136(US9562012, 6 | ethyl (2s)-2-ethoxy-3-{4-[(4-methox...)
Affinity DataIC50: 1.95E+5nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/3/2018
Entry Details
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Centaurus Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 228145BDBM228145(US9562012, 15 | (2r)-2-ethoxy-n-methoxy-3-{4-[2-(3...)
Affinity DataIC50: 2.00E+5nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/3/2018
Entry Details
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Centaurus Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 228144BDBM228144(US9562012, 14 | (2r)-2-ethoxy-n-methoxy-3-{4-[2-(3...)
Affinity DataIC50: 2.50E+5nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/3/2018
Entry Details
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Centaurus Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 228139BDBM228139(US9562012, 9 | (2s)-2-ethoxy-n-methoxy-3-{4-[(4-me...)
Affinity DataIC50: 2.50E+5nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/3/2018
Entry Details
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Centaurus Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 228135BDBM228135(US9562012, 5 | (2s)-2-ethoxy-n-hydroxy-3-[4-(pyrid...)
Affinity DataIC50: 2.50E+5nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/3/2018
Entry Details
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Centaurus Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 228133BDBM228133(US9562012, 3 | (2s)-2-ethoxy-n-hydroxy-3-{4-[(3-io...)
Affinity DataIC50: 2.50E+5nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/3/2018
Entry Details
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Centaurus Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 228149BDBM228149(US9562012, 19 | (2r)-2-ethoxy-3-{4-[(2r)-2-hydroxy...)
Affinity DataIC50: 2.50E+5nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/3/2018
Entry Details
US Patent

TargetNuclear receptor coactivator 2 [740-753]()
Centaurus Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 228148BDBM228148(US9562012, 18 | (2r)-2-ethoxy-n-hydroxy-3-{4-[(2s)...)
Affinity DataIC50: 2.50E+5nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/3/2018
Entry Details
US Patent